Antibody Conjugates for the Treatment of Cancer
- 1 October 1992
- journal article
- Published by Wiley in Immunological Reviews
- Vol. 129 (1), 57-80
- https://doi.org/10.1111/j.1600-065x.1992.tb01419.x
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Clinical Pharmacology, Metabolism, and Tissue Distribution of 90Y-Labeled Monoclonal Antibody B72.3 After Intraperitoneal AdministrationJNCI Journal of the National Cancer Institute, 1991
- In vitro antitumor activity of 2'-deoxy-5-fluorouridine-monoclonal antibody conjugatesBioconjugate Chemistry, 1991
- Development of human anti‐murine antibody (HAMA) response in patientsImmunology & Cell Biology, 1990
- The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancerBioconjugate Chemistry, 1990
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Phase I Study of an Anti-Breast Cancer Immunotoxin by Continuous Infusion: Report of a Targeted Toxic Effect Not Predicted by Animal StudiesJNCI Journal of the National Cancer Institute, 1989
- Intraperitoneal radioimmunotherapy for ovarian cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Anti‐tumour activity of aminopterin‐monoclonal antibody conjugates; in vitro and in vivo comparison with methotrexate‐monoclonal antibody conjugatesImmunology & Cell Biology, 1987
- Transfectomas Provide Novel Chimeric AntibodiesScience, 1985
- DEPRESSION BY ANTIBODY OF THE IMMUNE RESPONSE TO HOMOGRAFTS AND ITS ROLE IN IMMUNOLOGICAL ENHANCEMENTThe Journal of Experimental Medicine, 1960